The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[(9-Isopropyl-2-piperazin-1-yl-9H-purin-6-ylamino)-methyl]-phenol ID: ALA2347585
PubChem CID: 71579078
Max Phase: Preclinical
Molecular Formula: C19H25N7O
Molecular Weight: 367.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)n1cnc2c(NCc3ccc(O)cc3)nc(N3CCNCC3)nc21
Standard InChI: InChI=1S/C19H25N7O/c1-13(2)26-12-22-16-17(21-11-14-3-5-15(27)6-4-14)23-19(24-18(16)26)25-9-7-20-8-10-25/h3-6,12-13,20,27H,7-11H2,1-2H3,(H,21,23,24)
Standard InChI Key: ITJWFMCRZKMTFA-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
21.1986 -20.4862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9861 -20.7362 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1986 -19.6571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4821 -20.8987 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9861 -19.3988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7696 -19.6571 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7696 -20.4862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4821 -19.2447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4736 -20.0696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4737 -18.4197 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0488 -20.8987 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2445 -21.5237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1945 -18.0072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1862 -17.1864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6861 -22.1362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0485 -21.6986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4696 -16.7865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8945 -16.7739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8861 -15.9574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4612 -15.9615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1737 -15.5490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3314 -20.4785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6127 -20.8874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6053 -21.7182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3227 -22.1385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0476 -21.7278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1719 -14.7241 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 1 2 0
5 3 1 0
6 7 2 0
7 4 1 0
8 3 2 0
9 2 1 0
10 8 1 0
11 7 1 0
12 2 1 0
13 10 1 0
14 13 1 0
15 12 1 0
16 12 1 0
17 14 2 0
18 14 1 0
19 18 2 0
20 17 1 0
21 19 1 0
8 6 1 0
9 5 2 0
20 21 2 0
11 22 1 0
11 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
21 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 367.46Molecular Weight (Monoisotopic): 367.2121AlogP: 2.13#Rotatable Bonds: 5Polar Surface Area: 91.13Molecular Species: BASEHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.55CX Basic pKa: 8.63CX LogP: 2.15CX LogD: 1.13Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.64Np Likeness Score: -0.91
References 1. Zatloukal M, Jorda R, Gucký T, Řezníčková E, Voller J, Pospíšil T, Malínková V, Adamcová H, Kryštof V, Strnad M.. (2013) Synthesis and in vitro biological evaluation of 2,6,9-trisubstituted purines targeting multiple cyclin-dependent kinases., 61 [PMID:22770608 ] [10.1016/j.ejmech.2012.06.036 ]